ClinicalTrials.Veeva

Menu

Risk Factors for PICC-Related Infection in 994 High-Risk Patients: The Role of Hb Levels and Sampling Frequency

M

Mahidol University

Status

Completed

Conditions

CLABSI - Central Line Associated Bloodstream Infection

Treatments

Other: Hemoglobin level

Study type

Observational

Funder types

Other

Identifiers

NCT07674992
Si327/2025

Details and patient eligibility

About

This retrospective cohort study aims to evaluate the incidence and clinical predictors of Central Line-Associated Bloodstream Infections (CLABSI) in patients receiving Peripherally Inserted Central Catheters (PICCs) via the Anesthesia Department.

Enrollment

1,239 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with PICC line more than 48 hours, performed by Anesthesia Department from January 2023 to December 2024

Exclusion criteria

  • Incomplete data
  • Patient with reported colonization of PICC line
  • Patient with unintended position of PICC line
  • Patient with any other central venous catheter besides PICC line
  • Patient with previously reported as CLABSI

Trial design

1,239 participants in 2 patient groups

non CLABSI
Description:
non CLABSI
CLABSI
Description:
Patient with CLABSI
Treatment:
Other: Hemoglobin level

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems